Pharmacogenomics in the treatment of rheumatoid arthritis: clinical implication and perspective

Author： Taniguchi Atsuo   Yamanaka Hisashi   Kamatani Naoyuki  

Publisher： Future Medicine

ISSN： 1741-0541

Source： Personalized Medicine, Vol.3, Iss.2, 2006-05, pp. : 151-163

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Treatment of rheumatoid arthritis with imatinib mesylate: clinical improvement in three refractory cases

By Eklund Kari   Joensuu Heikki  

Annals of Medicine, Vol. 35, Iss. 8, 2003-12 ,pp. : 640-640

Informa Healthcare

Access to resources Recommend Favorite

Generalization and Extrapolation of Treatment Effects From Clinical Studies in Rheumatoid Arthritis

By  

ARTHRITIS CARE AND RESEARCH, Vol. 66, Iss. 7, 2014-07 ,pp. : 998-1007

John Wiley & Sons Inc

Access to resources Recommend Favorite

Treatment of early rheumatoid arthritis

By Raza Karim   Salmon Mike   Buckley Christopher D  

Therapy, Vol. 2, Iss. 4, 2005-07 ,pp. : 659-668

Future Medicine

Access to resources Recommend Favorite

Certolizumab pegol for the treatment of rheumatoid arthritis

By Modesto I   Spinello M   Nicchi F   Cottone M  

Therapy, Vol. 8, Iss. 4, 2011-07 ,pp. : 391-402

Future Medicine

Access to resources Recommend Favorite

Subcutaneous abatacept for the treatment of rheumatoid arthritis

By Schiff Michael  

British Journal of Rheumatology , Vol. 52, Iss. 6, 2013-06 ,pp. : 986-997

Oxford University Press

Access to resources Recommend Favorite